Recombinant human follicle-stimulating hormone treatment leads to normal follicular growth, estradiol secretion, and pregnancy in a World Health Organization group II anovulatory woman.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples